Stem Cell Treatment For Glioma May Prevent Tumor Recurrence, Improve Quality Of Life
A stem cell-based therapy from Cellonis Biotechnologies combines the latest stem cell and immuno technology with the benefits of Traditional Chinese Medicine.
Inger Marie Olsen from Norway recently concluded a cycle of the treatment in Beijing, and she has been in a stable condition since the first cycle in September 2009.
“For brain cancer patients after surgery, the combined DC-CIK and stem cell therapy from Cellonis Biotechnologies can be a very effective method in preventing cancer recurrence,” Dr. Dinggang Li said. “This is a new hope for cancer patients.” Li has been guiding the treatment of Inger.
“Inger’s general condition has improved very much,” he said. “She can now speak, move, eat and sleep much better, she has improved a great deal. I think her quality of life is almost back to normal.”
“I was diagnosed with cancer in 2005,” Inger said. “I had chemotherapy, radiotherapy and three surgeries, but the cancer still came back. A friend of mine read about this new therapy on the internet and the people of my town arranged a fund to help me come here.”
The Cellonis cancer therapy combines the latest research into cancer stem cells with the advantages of Traditional Chinese Medicine to create a unique cancer treatment. Dendritic cells, cultured and processed from blood taken from the patient’s body, are loaded with glioma stem cell antigens to create a vaccine that can activate the immune system to kill cancer cells as well as the cancer stem cells responsible for tumor initiation and recurrence. Another patient like Inger with glioma who undertook the treatment earlier this year, Guy Spavold from Canada, has been in stable condition since April with a good quality of life.
Read the full press release on this treatment here.